Budesonide
Back to searchMolecule Structure
Scientific Name
Budesonide
Description of the Drug
Budesonide is a corticosteroid used to treat Crohn’s disease, asthma, COPD, hay fever and allergies, and ulcerative colitis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01222
http://www.drugbank.ca/drugs/DB01222
Brand Name(s)
Aircort, Budeflam aquanase, Budelin novolizer, Budenofalk, Budesonide, Cortiment, Duoresp spiromax, Entocort, Entocort cr, Entocort ec, Ortikos, Preferid, Pulmaxan, Pulmicort, Pulmicort flexhaler, Pulmicort l.s., Pulmicort respules, Rhinocort, Rhinocort allergy, Rhinocort aqua, Rhinocort aqua 64, Symbicort, Uceris
Company Owner(s)
Apotex Inc Richmond Hill, Salix Pharmaceuticals Inc, Impax Laboratories Inc, Alvogen Inc, Sciecure Pharma Inc, Padagis Us Llc, Sun Pharma Global Fze, Barr Laboratories Inc Sub Teva Pharmaceuticals Usa, Sun Pharmaceutical Industries Ltd, Zydus Pharmaceuticals Usa Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Glucocorticoid receptor | SINGLE PROTEIN | AGONIST | CHEMBL2034 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4096 | ||||||
| Human Metabolome Database | HMDB0015353 | ||||||
| DrugBank | DB01222 | ||||||
| PubChem: Thomson Pharma | 14929955 | 14807548 | |||||
| PubChem | 5281004 | ||||||
| LINCS | LSM-1472 | ||||||
| Nikkaji | J11.656D | ||||||
| BindingDB | 50354850 | ||||||
| EPA CompTox Dashboard | DTXSID8020202 | ||||||
| DrugCentral | 419 | ||||||
| Brenda | 52466 | ||||||
| ChemicalBook | CB0313122 | ||||||
| Guide to Pharmacology | 7434 | ||||||
| rxnorm | ENTOCORT | BUDESONIDE | ORTIKOS | RHINOCORT | SYMBICORT | UCERIS | PULMICORT |
| PubChem: Drugs of the Future | 12013315 | ||||||
| ChEBI | 3207 | ||||||
| NIH Clinical Collection | SAM002699898 |
